Suppression of Fibulin 5 Attenuated Pulmonary Arterial Hypertension Associated with Congenital Heart Disease via Mitigating Pulmonary Arterial Smooth Muscle Cell Dysfunction

Back

ESC Professional Premium Access

Suppression of Fibulin 5 Attenuated Pulmonary Arterial Hypertension Associated with Congenital Heart Disease via Mitigating Pulmonary Arterial Smooth Muscle Cell Dysfunction

Session: Novel insights into vascular remodelling

Topic: Hypertension, Pulmonary Hypertension

Speaker: Doctor Y. Yang (Beijing, CN)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Yicheng Yang

Beijing (China)

0 follower

5 more presentations in this session

Novel balloon catheter containing therapeutic mRNA with smart RNA switch alleviate restenosis after vascular injury

Speaker: Doctor Y. Fu (Shanghai, CN)

ERBB4 activation prevents microvascular dysfunction in a large animal model of hypertensive heart disease

Speaker: Doctor T. Bringmans (Mechelen, BE)

Impact of neonatal hyperoxia on the development of the coronary vascular bed: an experimental model for the study of cardiomyopathy associated with premature birth

Speaker: Doctor P. Girault-Sotias (Montreal, CA)

Parathyroid hormone exacerbates pulmonary hypertension via parathyroid hormone receptors on pulmonary artery smooth muscle cells

Speaker: Assistant Professor Y. Joki (Tokyo, JP)

The novel role of complement 3 in Wnt5a-mediated vascular smooth muscle cell calcification

Speaker: Doctor I. Badi (Oxford, GB)

Access the full session

Novel insights into vascular remodelling

Speakers: Doctor Y. Yang, Doctor Y. Fu, Doctor T. Bringmans, Doctor P. Girault-Sotias, Assistant Professor Y. Joki...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources